A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

RP McLaughlin; JC He; VE van der Noord; J Redel; John Foekens; John Martens; Marcel Smid; YH Zhang; B van de Water

doi:10.1186/s13058-019-1161-9

A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

RP McLaughlin, JC He, VE van der Noord, J Redel, John Foekens, John Martens, Marcel Smid, YH Zhang, B van de Water

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

50 Citations (Scopus)

37 Downloads (Pure)

Original language	Undefined/Unknown
Article number	77
Journal	Breast Cancer Research
Volume	21
DOIs	https://doi.org/10.1186/s13058-019-1161-9
Publication status	Published - 2019

Research programs

EMC MM-03-86-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s13058-019-1161-9

Repub_117933_O-A.pdfFinal published version, 2.58 MB

http://hdl.handle.net/1765/117933

Cite this

@article{34f1ee04a05e4986a3c22b8ed8762208,

title = "A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy",

author = "RP McLaughlin and JC He and \{van der Noord\}, VE and J Redel and John Foekens and John Martens and Marcel Smid and YH Zhang and \{van de Water\}, B",

year = "2019",

doi = "10.1186/s13058-019-1161-9",

language = "Undefined/Unknown",

volume = "21",

journal = "Breast Cancer Research",

issn = "1465-5411",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

AU - McLaughlin, RP

AU - He, JC

AU - van der Noord, VE

AU - Redel, J

AU - Foekens, John

AU - Martens, John

AU - Smid, Marcel

AU - Zhang, YH

AU - van de Water, B

PY - 2019

Y1 - 2019

U2 - 10.1186/s13058-019-1161-9

DO - 10.1186/s13058-019-1161-9

M3 - Article

C2 - 31262335

SN - 1465-5411

VL - 21

JO - Breast Cancer Research

JF - Breast Cancer Research

M1 - 77

ER -